DYN

Dyne Therapeutics, Inc.

29.07 USD
-0.06 (-0.21%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Dyne Therapeutics, Inc. stock is up 38.17% since 30 days ago. The next earnings date is Mar 15, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 70% of the previous 11 March’s closed higher than February. In the last 10 Unusual Options Trades, there were 4 PUTs, 6 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Feb 18:50 15 Mar, 2024 25.00 PUT 246 1
12 Feb 20:38 15 Mar, 2024 25.00 PUT 219 1
12 Feb 20:51 15 Mar, 2024 25.00 PUT 178 1
12 Feb 20:53 16 Feb, 2024 22.50 CALL 300 1320
13 Feb 15:48 15 Mar, 2024 22.50 PUT 163 604
14 Feb 20:41 15 Mar, 2024 30.00 CALL 476 1031
23 Feb 19:36 19 Apr, 2024 30.00 CALL 766 0
27 Feb 20:46 15 Mar, 2024 22.50 CALL 90 421
27 Feb 20:55 15 Mar, 2024 22.50 CALL 112 421
01 Mar 16:03 15 Mar, 2024 30.00 CALL 203 2932

About Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a muscle disease company, focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.